|
US3340276A
(en)
|
1964-04-01 |
1967-09-05 |
Ciba Geigy Corp |
3, 4-diphenyl-chromans
|
|
DE1518002C3
(de)
|
1965-01-02 |
1975-01-23 |
Merck Patent Gmbh, 6100 Darmstadt |
Isoflavane und Isoflavene und Verfahren zu Ihrer Herstellung sowie diese enthaltende Arzneimittel
|
|
DE1543749A1
(de)
|
1966-02-16 |
1969-12-11 |
Merck Ag E |
Verfahren zur Herstellung von 3,4-cis-4-Aryl-isoflavanen
|
|
GB1433013A
(enExample)
|
1973-06-08 |
1976-04-22 |
|
|
|
US4264509A
(en)
|
1977-06-08 |
1981-04-28 |
Z-L Limited Partnership |
Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
|
|
US4157984A
(en)
|
1977-06-08 |
1979-06-12 |
Z-L Limited |
Antioxidants, antioxidant compositions and methods of preparing and using same
|
|
US4218489A
(en)
|
1977-06-08 |
1980-08-19 |
Z-L Limited Partnership |
Antioxidants, antioxidant compositions and methods of preparing and using same
|
|
US4232122A
(en)
|
1979-01-17 |
1980-11-04 |
Z-L Limited Partnership |
Antioxidants, antioxidant compositions and methods of preparing and using same
|
|
US4368264A
(en)
|
1979-03-19 |
1983-01-11 |
Z-L Limited Partnership |
Fermentation methods of preparing ergostadientriols
|
|
US4234577A
(en)
|
1979-03-19 |
1980-11-18 |
Z-L Limited Partnership |
Ergostadientriols, compositions containing same, and methods of preparing and using same
|
|
US4366248A
(en)
|
1979-04-11 |
1982-12-28 |
Z-L Limited Partnership |
Fermentation method of preparing antioxidants
|
|
US4390559A
(en)
|
1979-04-11 |
1983-06-28 |
Z-L Limited Partnership |
Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
|
|
US4366082A
(en)
|
1979-04-11 |
1982-12-28 |
Z-L Limited Partnership |
Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
|
|
US4447622A
(en)
|
1981-09-22 |
1984-05-08 |
Council Of Scientific And Industrial Research Rafi Marg |
Preparation of l- and d-isomers of dl-3,4-trans-2,2-disubstituted-3,4-diarylchromans and derivatives thereof
|
|
US4644012A
(en)
|
1983-12-21 |
1987-02-17 |
Takeda Chemical Industries, Ltd. |
Treatment for osteoporosis
|
|
GB8626344D0
(en)
|
1986-11-04 |
1986-12-03 |
Zyma Sa |
Bicyclic compounds
|
|
US5059609A
(en)
|
1987-10-19 |
1991-10-22 |
Pfizer Inc. |
Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases
|
|
MX13485A
(es)
|
1987-10-19 |
1993-05-01 |
Pfizer |
Procedimiento para obtener tetralinas, cromados y compuestos relacionados, sustituidos
|
|
US5002935A
(en)
|
1987-12-30 |
1991-03-26 |
University Of Florida |
Improvements in redox systems for brain-targeted drug delivery
|
|
KR0166088B1
(ko)
|
1990-01-23 |
1999-01-15 |
. |
수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
|
|
US5376645A
(en)
|
1990-01-23 |
1994-12-27 |
University Of Kansas |
Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
|
|
DE69023906T2
(de)
|
1990-08-09 |
1996-04-11 |
Council Scient Ind Res |
Benzopyrane und Verfahren zu deren Herstellung.
|
|
CA2146005A1
(en)
|
1992-10-21 |
1994-04-28 |
Charles W. Murtiashaw, Iii |
Enantiomeric cis-3-(4,6-dihydroxychroman-3-yl-methyl)benzoic acids
|
|
US5280040A
(en)
|
1993-03-11 |
1994-01-18 |
Zymogenetics, Inc. |
Methods for reducing bone loss using centchroman derivatives
|
|
US5451603A
(en)
|
1993-03-11 |
1995-09-19 |
Zymogenetics, Inc. |
3,4-diarylchromans for treatment of dermatitis
|
|
US5389646A
(en)
|
1993-12-30 |
1995-02-14 |
Zymogenetics, Inc. |
Methods for treatment and prevention of bone loss using 2,3-benzopyrans
|
|
US5792776A
(en)
|
1994-06-27 |
1998-08-11 |
Cytomed, Inc., |
Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
|
|
HUP9702244A3
(en)
|
1995-01-13 |
1999-12-28 |
Novo Nordisk As |
Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders
|
|
WO1996021442A1
(en)
|
1995-01-13 |
1996-07-18 |
Novo Nordisk A/S |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of idiopathic or physiologic gynaecomastia
|
|
CN1168098A
(zh)
|
1995-01-13 |
1997-12-17 |
诺沃挪第克公司 |
3,4-二苯基苯并二氢吡喃在生产用于治疗或预防高脂蛋白血症、高甘油三酯血症、高脂血症或高胆固醇血症或动脉硬化或用于抗凝治疗的药物组合物中的用途
|
|
CZ212097A3
(en)
|
1995-01-20 |
1997-11-12 |
Novo Nordisk As |
Use of 3,4-diphenylchromans for preparing a medicament intended for treating or prophylaxis of cerebral degenerative diseases
|
|
EP0804188A1
(en)
|
1995-01-20 |
1997-11-05 |
Novo Nordisk A/S |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for vasodilatory treatment or prophylaxis
|
|
TW448046B
(en)
|
1995-01-20 |
2001-08-01 |
Novo Nordisk As |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity
|
|
US5849461A
(en)
|
1995-08-01 |
1998-12-15 |
Shin-Etsu Chemical Co., Ltd. |
Chemically amplified positive resist composition
|
|
HUP9902683A3
(en)
|
1996-01-11 |
2001-08-28 |
Novo Nordisk As |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of menopausal symptoms
|
|
US5726202A
(en)
|
1996-01-11 |
1998-03-10 |
Novo Nordisk A/S |
Benign prostatic hypertrophy
|
|
US5883118A
(en)
|
1996-01-11 |
1999-03-16 |
Nova Nordisk A/S |
Prostatic carcinoma
|
|
US5747059A
(en)
|
1996-01-11 |
1998-05-05 |
Novo Nordisk A/S |
Atrophy of skin/mucous membrane
|
|
US5756539A
(en)
|
1996-07-11 |
1998-05-26 |
Novo Nordis A/S |
3, 4-diphenyl chromans for inhibiting one or more psychiatric disorders
|
|
WO1998002156A1
(en)
|
1996-07-12 |
1998-01-22 |
Novo Nordisk A/S |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for lowering intraocular pressure
|
|
WO1998002154A1
(en)
|
1996-07-12 |
1998-01-22 |
Novo Nordisk A/S |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more symptoms of premenstrual syndrome
|
|
AUPO203996A0
(en)
|
1996-08-30 |
1996-09-26 |
Novogen Research Pty Ltd |
Therapeutic uses
|
|
GB9621757D0
(en)
|
1996-10-18 |
1996-12-11 |
Ciba Geigy Ag |
Phenyl-substituted bicyclic heterocyclyl derivatives and their use
|
|
US6043269A
(en)
|
1996-10-28 |
2000-03-28 |
Novo Nordisk A/S |
cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
|
IL129623A0
(en)
|
1996-10-28 |
2000-02-29 |
Novo Nordisk As |
Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
|
US5985306A
(en)
|
1996-10-28 |
1999-11-16 |
Novo Nordisk A/S |
(+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes
|
|
ZA979644B
(en)
|
1996-10-28 |
1998-04-28 |
Novo Nordisk As |
Heterocyclic compounds, compositions and uses.
|
|
CA2269974A1
(en)
|
1996-10-28 |
1998-05-07 |
Paul Stanley Bury |
Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
|
CA2270057A1
(en)
|
1996-10-28 |
1998-05-07 |
Novo Nordisk A/S |
Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
|
US5958967A
(en)
|
1996-10-28 |
1999-09-28 |
Novo Nordisk A/S |
Cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
|
US6316494B1
(en)
|
1996-10-28 |
2001-11-13 |
Novo Nordisk A/S |
cis3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
|
CA2270113A1
(en)
|
1996-10-28 |
1998-05-07 |
Poul Jacobsen |
Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
|
JP2001502703A
(ja)
|
1996-10-28 |
2001-02-27 |
ノボ ノルディスク アクティーゼルスカブ |
（−）―３，４―トランス―ジアリールクロマンの調製方法
|
|
AU4772297A
(en)
|
1996-10-28 |
1998-05-22 |
Novo Nordisk A/S |
Novel (cis)-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
|
US5919817A
(en)
|
1996-10-28 |
1999-07-06 |
Novo Nordisk A/S |
Cis-3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
|
AU4772397A
(en)
|
1996-10-28 |
1998-05-22 |
Novo Nordisk A/S |
Novel (cis)-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
|
ES2191170T3
(es)
|
1996-10-28 |
2003-09-01 |
Novo Nordisk As |
Nuevos (-)-enantiomeros de derivados de cis-3,4-cromano utiles en la prevencion y tratamiento de sindromes o enfermedades relacionadas con el estrogeno.
|
|
US5994390A
(en)
|
1996-10-28 |
1999-11-30 |
Novo Nordisk |
Trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
|
ATE225782T1
(de)
|
1996-12-13 |
2002-10-15 |
Chugai Pharmaceutical Co Ltd |
Benzopyranderivate
|
|
WO1998032437A1
(en)
|
1997-01-29 |
1998-07-30 |
Novo Nordisk A/S |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more psychiatric disorders
|
|
ZA98681B
(en)
|
1997-01-29 |
1998-07-29 |
Novo Nordisk As |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibition senescense-associated motor impairment
|
|
AU5550298A
(en)
|
1997-01-29 |
1998-08-25 |
Novo Nordisk A/S |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical compositionfor increasing libido in post-menopausal women
|
|
US5874418A
(en)
|
1997-05-05 |
1999-02-23 |
Cydex, Inc. |
Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use
|
|
AUPP112497A0
(en)
|
1997-12-24 |
1998-01-22 |
Novogen Research Pty Ltd |
Compositions and method for protecting skin from UV induced immunosupression and skin damage
|
|
WO1999049862A1
(en)
|
1998-03-30 |
1999-10-07 |
The University Of Mississippi |
Isoflavones for treating giardiasis and malaria
|
|
WO1999055898A1
(en)
|
1998-04-28 |
1999-11-04 |
Novo Nordisk A/S |
Enzymatic resolvation for obtaining a (-)-3,4-trans-diarylchroman
|
|
FR2778404B1
(fr)
|
1998-05-06 |
2000-06-30 |
Hoechst Marion Roussel Inc |
Derives du dihydro ou tetrahydronaphtalene, et les compositions pharmaceutiques les renfermant
|
|
US6465445B1
(en)
|
1998-06-11 |
2002-10-15 |
Endorecherche, Inc. |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
|
|
KR20000001793A
(ko)
|
1998-06-13 |
2000-01-15 |
이경하 |
신규한 벤조피란 또는 티오벤조피란 유도체
|
|
US6509323B1
(en)
|
1998-07-01 |
2003-01-21 |
California Institute Of Technology |
Linear cyclodextrin copolymers
|
|
FR2789685B1
(fr)
|
1999-02-15 |
2001-05-04 |
Univ Lille Sciences Tech |
Procede de fabrication de polymeres solubles et insolubles a base de cyclodextrine(s) et/ou de derives de cyclodextrine(s) et polymeres solubles a base de cyclodextrine(s) et/ou de derives de cyclodextrine(s)
|
|
AUPP868599A0
(en)
|
1999-02-15 |
1999-03-11 |
Novogen Research Pty Ltd |
Production of isoflavone derivatives
|
|
AUPQ008299A0
(en)
|
1999-04-30 |
1999-05-27 |
G.J. Consultants Pty Ltd |
Isoflavone metabolites
|
|
WO2001007031A1
(en)
|
1999-07-26 |
2001-02-01 |
Shionogi & Co., Ltd. |
Benzene derivatives and immunopotentiating compositions or drug-sensitivity restoring agents containing the same
|
|
AUPQ266199A0
(en)
|
1999-09-06 |
1999-09-30 |
Novogen Research Pty Ltd |
Compositions and therapeutic methods involving isoflavones and analogues thereof
|
|
US6528042B1
(en)
|
1999-10-08 |
2003-03-04 |
Galileo Laboratories, Inc. |
Compositions of flavonoids for use as cytoprotectants and methods of making and using them
|
|
AU7896100A
(en)
|
1999-10-14 |
2001-04-23 |
Endorecherche Inc. |
Selective estrogen receptor modulators in the treatment or reduction of the riskof acquiring hypertension, cardiovascular diseases, and insulin resistance
|
|
EP1241165A4
(en)
|
1999-12-13 |
2003-03-19 |
Chugai Pharmaceutical Co Ltd |
OPTICALLY ACTIVE CHROMAN AND THIOCHROME DERIVATIVES
|
|
US6479467B1
(en)
|
1999-12-16 |
2002-11-12 |
Eastman Chemical Company |
Cyclodextrin ethers
|
|
EP1251855A1
(en)
|
2000-01-28 |
2002-10-30 |
Endorecherche, Inc. |
Selective estrogen receptor modulators in combination with estrogens
|
|
AU2001255709A1
(en)
|
2000-05-11 |
2001-11-20 |
Eastman Chemical Company |
Acylated cyclodextrin guest inclusion complexes
|
|
FI20001593A7
(fi)
|
2000-07-03 |
2002-01-04 |
Orion Yhtymo Oyj |
Comt-entsyymiõ inhiboivaa aktiivisuutta omaavia kumariinijohdannaisia
|
|
CN1250505C
(zh)
|
2000-08-31 |
2006-04-12 |
科学工业研究院 |
制备1－丙基－2，4，5－三甲氧基苯的改进方法
|
|
WO2002055562A2
(en)
|
2001-01-11 |
2002-07-18 |
Eastman Chem Co |
Cyclodextrin sulfonates, guest inclusion complexes, methods of making the same and related materials
|
|
WO2002059113A1
(en)
|
2001-01-24 |
2002-08-01 |
Chiesi Farmaceutici S.P.A. |
2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
|
|
US7026304B2
(en)
|
2001-02-14 |
2006-04-11 |
Akzo Nobel N.V. |
2-alkylated-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
|
|
EP1417169A2
(en)
|
2001-08-11 |
2004-05-12 |
Bristol-Myers Squibb Pharma Company |
Selective estrogen receptor modulators
|
|
CN1668287B
(zh)
|
2001-09-06 |
2012-03-28 |
赛诺克思公司 |
3-脱氧类黄酮在制备抑制t淋巴细胞活性的药物中的用途
|
|
AUPR846401A0
(en)
|
2001-10-25 |
2001-11-15 |
Novogen Research Pty Ltd |
6-Hydroxy isoflavones, derivatives and medicaments involving same
|
|
WO2003063859A1
(en)
|
2002-01-14 |
2003-08-07 |
Nordic Bioscience A/S |
Suppression of cartilage degradation via the estrogen receptor
|
|
EP1503751A4
(en)
|
2002-04-09 |
2007-08-01 |
Novogen Res Pty Ltd |
THERAPEUTIC PROCESSES AND COMPOSITIONS WITH ISOFLAV-3-EN AND ISOFLAVAN STRUCTURES
|
|
AU2002951833A0
(en)
|
2002-10-02 |
2002-10-24 |
Novogen Research Pty Ltd |
Compositions and therapeutic methods invloving platinum complexes
|
|
BR0315198A
(pt)
|
2002-10-09 |
2005-08-30 |
Insert Therapeutics Inc |
Materiais e composições à base de ciclodextrina e usos relacionados aos mesmos
|
|
CA2546643A1
(en)
|
2003-11-18 |
2005-06-02 |
Novogen Research Pty Ltd |
Isoflavonoid prodrugs, compositions thereof and therapeutic methods involving same
|
|
CN101123958A
(zh)
|
2003-11-19 |
2008-02-13 |
诺沃根研究股份有限公司 |
联合放射疗法与化学疗法的组合物和方法
|
|
DE102004002787A1
(de)
|
2004-01-19 |
2005-08-11 |
Merck Patent Gmbh |
Flavonoid-Komplexe
|
|
ES2377073T3
(es)
|
2004-09-21 |
2012-03-22 |
Marshall Edwards, Inc. |
Derivados de cromano sustituidos, medicamentos y utilización en terapia
|
|
CN101056868B
(zh)
|
2004-09-21 |
2012-05-02 |
马休爱德华兹股份有限公司 |
取代的苯并二氢吡喃衍生物、药物及其在治疗中的应用
|
|
EP2436680B1
(en)
|
2004-09-21 |
2016-05-18 |
Marshall Edwards, Inc. |
Chroman derivatives, medicaments and use in therapy
|
|
JP4976649B2
(ja)
|
2004-09-21 |
2012-07-18 |
マーシャル エドワーズ，インク． |
化合物
|
|
US8080675B2
(en)
|
2004-09-21 |
2011-12-20 |
Marshall Edwards, Inc. |
Chroman derivatives, medicaments and use in therapy
|
|
CA2668008A1
(en)
|
2006-10-30 |
2008-05-08 |
Novogen Research Pty Ltd |
Prevention and reversal of chemotherapy-induced peripheral neuropathy
|
|
EP2120925A4
(en)
|
2007-03-16 |
2010-04-07 |
Novogen Res Pty Ltd |
METHOD FOR INTRODUCING AUTOPHAGIA
|
|
CA2738328A1
(en)
|
2008-08-29 |
2010-03-04 |
Novogen Research Pty Ltd |
Immunomodulating activities
|
|
CN102596196A
(zh)
|
2008-10-22 |
2012-07-18 |
诺沃根研究控股有限公司 |
用于诱导程序性细胞死亡的方法
|
|
CA2641541A1
(en)
|
2008-10-22 |
2010-04-22 |
Novogen Research Pty Ltd. |
Methods for inducing programmed cell death
|
|
WO2012061409A1
(en)
|
2010-11-01 |
2012-05-10 |
Marshall Edwards, Inc. |
Isoflavonoid compounds and methods for the treatment of cancer
|
|
US20120251630A1
(en)
*
|
2011-03-29 |
2012-10-04 |
Marshall Edwards, Inc. |
Remission therapy of cancer with isoflavonoids
|
|
US20140093498A1
(en)
|
2012-09-28 |
2014-04-03 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical combinations comprising dual angiopoietin-2 / dll4 binders and anti-vegf-r agents
|
|
ES2643407T3
(es)
|
2014-02-07 |
2017-11-22 |
Novogen Ltd. |
Compuestos de benzopirano funcionalizados y uso de los mismos
|
|
PT3253208T
(pt)
*
|
2015-02-02 |
2021-06-17 |
The Spanish National Cancer Res Centre |
Terapêuticas de combinação para utilização no tratamento do cancro da mama
|